Delta variant spread renews vaccine urgency
Published 5:33 pm Thursday, July 29, 2021
The arrival of the COVID-19 vaccines brought great hope in the battle against the deadly pandemic that has affected our way of life for nearly a year and a half. Now, more than seven months into the largest vaccination effort in history, the data and science is clear: the vaccines are effective, but only if people get their “dose of hope.”
The continued spread of the virus and the arrival of new variants is an urgent reminder that this pandemic is not over yet, and that we still have to assure vaccination for everyone to protect our communities. Right now, the Delta variant is quickly becoming the dominant virus variant. We know that this variant is easily spread and has many of the same devastating health impacts as previous variants. We also know that the vaccines are highly effective at both preventing the spread of the virus and drastically reducing the impact on those it infects.
It was not long ago that some hospitals around the country celebrated having zero COVID-19 patients in their intensive care units. Doctors, nurses and other staff rejoiced at this welcomed respite. Here at Vidant, we never quite got to zero, but our numbers hit a new low in the spring. Now, hospitalizations are back on the rise and nearly all hospitalized COVID-19 patients – many of whom are battling for their lives – are unvaccinated.
As we have continued to learn more and more about this virus over the past year and a half, we can confidently say that ending up hospitalized with serious complications from COVID-19 is mostly avoidable now. The vaccines are safe, effective and widely available at local hospitals, clinics, health departments, pharmacies and more.
We can still see the light at the end of the tunnel but the Delta variant is dimming our view. Help us end this pandemic by receiving your COVID-19 vaccine as soon as possible by visiting VidantHealth.com/Vaccinate or by calling 252-847-8000.
Dr. T. Ryan Gallaher is an infectious disease specialist at Vidant.